Delphia (USA)’s Transmedics TMDX Stock Holding History

Delphia (USA)’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,394	Closed	-$201K	–	178
2023 Q2	$201K	Buy	+2,394	New	+$183K	0.32%	162

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Delphia (USA)'s TMDX Position: Q3 2023 in Review

Delphia (USA) sold out of Transmedics (TMDX) in Q3 2023, closing a stake of 2,394 shares — an estimated $201K sold.

Delphia (USA) first reported a position in TMDX in Q2 2023 and held it in 1 quarter. The position peaked at $201K in Q2 2023. 221 funds tracked by Wall St. Rank hold TMDX as of Q3 2023.

Delphia (USA) reported no remaining Transmedics position as of Q3 2023 after selling out during the quarter.
Delphia (USA) sold 2,394 Transmedics shares in Q3 2023, an estimated $201K.
Delphia (USA) first reported a position in Transmedics in Q2 2023 and held it in 1 quarter.
Delphia (USA)'s Transmedics position peaked at $201K in Q2 2023.
221 funds tracked by Wall St. Rank held Transmedics as of Q3 2023.

Based on Delphia (USA)'s 13F filing for Q3 2023, filed 15 Nov 2023.